COSCIENS Biopharma Inc.
CSCIF · Perfumes, Cosmetics & Other Toilet Preparations · EDGAR filings ↗
Grade
D45gen composite 15pct→48; net margin <-100%; net + operating loss
Notable findings
- No interest coverageInterest coverage -63.58 (cannot cover interest)
- Cash burnNegative free cash flow (-9.2M)
- Customer concentration~84% of revenue from one customer/distributor — We have a history of operating losses and are currently dependent on one distribution partner for over 84% of our revenues
- Net lossNet loss (net margin -138.1%)
- Revenue declineRevenue -46.8% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Supply chain
Customers (1)
- Symrise AG 84% of rev
Suppliers (0)
Named in the 10-K; linked when we track them.
Key metrics
Gross margin
35.3%
Operating margin
-142.5%
Net margin
-138.1%
Return on equity
-269.6%
Return on assets
-48.3%
ROIC
-219.6%
Revenue growth (QoQ)
-46.8%
Interest coverage
-63.6×
Current ratio
3.2×
Free cash flow
-$9M
EBITDA
-$9M
Tangible book value
$4M
Cash & investments
$7M
Cash runway
3q
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2026-03-25 | 2025-12-31 | 0001493152-26-012703 ↗ |
| 20-F | 2025-04-09 | 2024-12-31 | 0001641172-25-003456 ↗ |
| 20-F | 2024-03-27 | 2023-12-31 | 0001493152-24-011401 ↗ |
| 20-F | 2023-03-23 | 2022-12-31 | 0001493152-23-008641 ↗ |
| 20-F | 2022-03-29 | 2021-12-31 | 0001493152-22-007933 ↗ |
| 40-F | 2021-03-25 | 2020-12-31 | 0001493152-21-006745 ↗ |
| 20-F | 2020-03-31 | 2019-12-31 | 0001493152-20-005347 ↗ |
| 20-F | 2019-04-01 | 2018-12-31 | 0001628280-19-003681 ↗ |
| 20-F | 2018-03-28 | 2017-12-31 | 0001628280-18-003635 ↗ |
| 20-F | 2017-03-16 | 2016-12-31 | 0001113423-17-000010 ↗ |
| 20-F | 2016-03-30 | 2015-12-31 | 0001113423-16-000039 ↗ |
| 20-F | 2015-03-17 | 2015-03-17 | 0001113423-15-000004 ↗ |